Actively Recruiting

Phase 2
Age: 18Years - 80Years
All Genders
Healthy Volunteers
NCT05275686

Effect of Novel Exhalational Delivery System With Fluticasone (EDS-FLU) on Eustachian Tube Dysfunction (ETD)

Led by Cedars-Sinai Medical Center · Updated on 2026-03-11

80

Participants Needed

4

Research Sites

297 weeks

Total Duration

On this page

Sponsors

C

Cedars-Sinai Medical Center

Lead Sponsor

S

Sacramento Ear, Nose & Throat

Collaborating Sponsor

AI-Summary

What this Trial Is About

Intranasal nasal steroid sprays are the mainstay of treatment for chronic Eustachian tube dysfunction despite having little supportive evidence in the literature. A novel, commercially available nasal spray delivery system is available now for fluticasone that improves its delivery to the nasopharynx. The hypothesis of this study is that fluticasone using the novel spray system is effective for Eustachian tube dysfunction (ETD).

CONDITIONS

Official Title

Effect of Novel Exhalational Delivery System With Fluticasone (EDS-FLU) on Eustachian Tube Dysfunction (ETD)

Who Can Participate

Age: 18Years - 80Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older and younger than 80 years
  • Chronic Eustachian tube dysfunction with symptoms in one or both ears lasting more than 3 months
  • ETDQ-7 score greater than 14.5
  • Type B, C, or As tympanometry
  • Female participants of childbearing potential must have a negative urine pregnancy test at screening and throughout the study
Not Eligible

You will not qualify if you...

  • Age younger than 18 years
  • History of ear surgery excluding myringotomy or myringotomy tubes
  • Use of any additional intranasal medication
  • Tympanic membrane perforation
  • Adhesive otitis media
  • Cholesteatoma or significant retraction pocket
  • Middle ear effusion
  • Nasopharyngeal tumor
  • History of head and neck cancer
  • History of head and neck irradiation
  • History of temporomandibular disorder or prior temporomandibular joint surgery
  • Any medical condition deemed inappropriate by the investigator

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 4 locations

1

Cedars-Sinai Medical Center

Los Angeles, California, United States, 90048

Actively Recruiting

2

Sacramento Ear, Nose & Throat

Sacramento, California, United States, 95661

Actively Recruiting

3

Indiana University

Indianapolis, Indiana, United States, 46202

Actively Recruiting

4

Ochsner Health System

New Orleans, Louisiana, United States, 70121

Actively Recruiting

Loading map...

Research Team

M

Missael Vasquez

CONTACT

L

Laura Sarmiento, CCRP

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here